ConductScience.org, home

Paper28344808

Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer.

Hege KM and 9 others. J Immunother Cancer, 2017. Cited by 281 papers, by iCite.

Cite this record

ConductScience Library. Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer. Papers, record 28344808. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28344808

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer.
PubMed
Journal
J Immunother Cancer
PubMed
Year
2017
PubMed
Publication types
Clinical Trial, Phase I, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
281
iCite
Relative citation ratio, by iCite
8.61
iCite
Revised in PubMed
2018-11-13
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hege KMKristen M
2Bergsland EKEmily K
3Fisher GAGeorge A
4Nemunaitis JJJohn J
5Warren RSRobert S
6McArthur JGJames G
7Lin AAAndy A
8Schlom JJeffrey
9June CHCarl H
10Sherwin SAStephen A

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, NeoplasmMajor topic
Colorectal NeoplasmsMajor topic
GlycoproteinsMajor topic
Receptors, Antigen, T-CellMajor topic
T-LymphocytesMajor topic
Aged
B-Lymphocytes
Carcinoembryonic Antigen
Dose-Response Relationship, Drug
Female
Gene Expression Regulation, Neoplastic
Humans
Infusions, Intravenous
Interferon-alpha
Male
Middle Aged
Neoplasm Metastasis

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
ZIABC010425NIH

Source NIH RePORTER

Download CSV of grants

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110975673T-cell killing of heterogenous tumor or viral targets with bispecific chimeric immune receptors.Cancer Gene Ther2000https://conductscience.org/library/papers/10975673PubMed
28195861Treatment of metastatic prostate carcinoma with radiolabeled antibody CC49.J Nucl Med1994https://conductscience.org/library/papers/8195861PubMed
39743337Chimeric receptors providing both primary and costimulatory signaling in T cells from a single gene product.J Immunol1998https://conductscience.org/library/papers/9743337PubMed
425317870Chimeric antigen receptor T cells for sustained remissions in leukemia.N Engl J Med2014https://conductscience.org/library/papers/25317870PubMed
512027564A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy.Mol Ther2002https://conductscience.org/library/papers/12027564PubMed
624553386Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.Sci Transl Med2014https://conductscience.org/library/papers/24553386PubMed
71705867The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways.Cell1991https://conductscience.org/library/papers/1705867PubMed
810887107Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection.Blood2000https://conductscience.org/library/papers/10887107PubMed
923939024Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma.Mol Ther2013https://conductscience.org/library/papers/23939024PubMed
102297774Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.Cancer Res1990https://conductscience.org/library/papers/2297774PubMed
1119934295Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria.Clin Cancer Res2009https://conductscience.org/library/papers/19934295PubMed
1220179677Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2.Mol Ther2010https://conductscience.org/library/papers/20179677PubMed
1326405231Remote control of therapeutic T cells through a small molecule-gated chimeric receptor.Science2015https://conductscience.org/library/papers/26405231PubMed
1423242161Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells.Nat Biotechnol2013https://conductscience.org/library/papers/23242161PubMed
159049790Antiidiotypic response against murine monoclonal antibodies reactive with tumor-associated antigen TAG-72.J Clin Immunol1997https://conductscience.org/library/papers/9049790PubMed
162810387In vivo distribution of adoptively transferred indium-111-labeled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanoma.J Natl Cancer Inst1989https://conductscience.org/library/papers/2810387PubMed
1722437939Adoptive immunotherapy for cancer: harnessing the T cell response.Nat Rev Immunol2012https://conductscience.org/library/papers/22437939PubMed
1821830940Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.N Engl J Med2011https://conductscience.org/library/papers/21830940PubMed
1922047558Inducible apoptosis as a safety switch for adoptive cell therapy.N Engl J Med2011https://conductscience.org/library/papers/22047558PubMed
202644399Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma.J Clin Oncol1989https://conductscience.org/library/papers/2644399PubMed

See all 43 referencesDownload CSV of references

Cited by201

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 281 citations.

PMIDTitleJournalYearIn PapersSource
42780573Carbohydrate antigen 72-4 and tumor-associated glycoprotein 72 - tumor marker: Past, present and future.World J Gastrointest Pathophysiol2026https://conductscience.org/library/papers/42780573PubMed
42761580Oncofetal antigens as emerging targets in chimeric antigen receptor (CAR)-T cell-based immunotherapies: opportunities and challenges.Front Cell Dev Biol2026https://conductscience.org/library/papers/42761580PubMed
42717494Multi-Omics-Enabled Precision Strategies for Overcoming CAR-T Therapy Limitations in Gastrointestinal Malignancies.Biofactors2026https://conductscience.org/library/papers/42717494PubMed
42677388From Glycocode to Precision Oncology: Therapeutic Strategies Targeting Aberrant O-GalNAc Glycosylation in Cancer.Chem Rev2026https://conductscience.org/library/papers/42677388PubMed
42416076Next-generation CAR-T engineering for colorectal cancer: integrating targets, tumor microenvironment barriers, and emerging strategies.Front Immunol2026https://conductscience.org/library/papers/42416076PubMed
42397032CAR T Cells Targeting O-Glycosylated Fibronectin Exhibit Potent Cytolytic Activity and Combine with Tumoral Toll-Like Receptor Agonism to Overcome Tumor Resistance.Cancer Immunol Res2026https://conductscience.org/library/papers/42397032PubMed
42340347Cancer-associated alterations in O-GalNAc glycosylation.Glycobiology2026https://conductscience.org/library/papers/42340347PubMed
42272961Adoptive T-cell therapies in the clinic.Bioeng Transl Med2026https://conductscience.org/library/papers/42272961PubMed
42039159CAR-T cell therapy for pancreatic cancer: Translating emerging targets and dual-targeting strategies from solid tumors.Front Immunol2026https://conductscience.org/library/papers/42039159PubMed
41939861Immunomodulation by glycosylation: bridging glycobiology to adaptive immunity and therapeutic innovation.Front Immunol2026https://conductscience.org/library/papers/41939861PubMed
41928316Bridging biomaterials and immunotherapy: hydrogel strategies for next-generation CAR-T cell treatment.Stem Cell Res Ther2026https://conductscience.org/library/papers/41928316PubMed
41928252In vivo CAR-T therapy: from molecular design to precision delivery.J Nanobiotechnology2026https://conductscience.org/library/papers/41928252PubMed
41639889Targeting urological cancers with CAR-T cell therapy: current landscape and future directions.J Transl Med2026https://conductscience.org/library/papers/41639889PubMed
41518483Immunogenicity of Gene and Cell Therapies.BioDrugs2026https://conductscience.org/library/papers/41518483PubMed
41383027Fine-tuning affinity and spacer design enhances T cell potency in DLL3 and BCMA CAR T cells.MAbs2026https://conductscience.org/library/papers/41383027PubMed
41005308Safe immunosuppression-resistant pan-cancer immunotherapeutics by velcro-like density-dependent targeting of tumor-associated carbohydrate antigens.Cell2025https://conductscience.org/library/papers/41005308PubMed
40981188Advances in Adoptive Cell Therapies in Cancer: From Mechanistic Breakthroughs to Clinical Frontiers and Overcoming Barriers.Med Sci (Basel)2025https://conductscience.org/library/papers/40981188PubMed
40969260Challenges and breakthroughs: current landscape and future prospects of CAR-T cell therapy clinical trials for solid tumors.Front Oncol2025https://conductscience.org/library/papers/40969260PubMed
40958736Peritoneal Immunosurgery: Immunotherapy Augmented Surgery for the Treatment of Peritoneal Cancers.J Surg Oncol2025https://conductscience.org/library/papers/40958736PubMed
40940743Engineering of Humanized PSMA-Directed CAR T Cells for Potent and Specific Elimination of Prostate Cancer Cells.Cells2025https://conductscience.org/library/papers/40940743PubMed

See all 201 cited byDownload CSV of cited by

Genes19

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD247919PubTator's text mininghttps://conductscience.org/library/genes/919NCBI Gene
CD28940PubTator's text mininghttps://conductscience.org/library/genes/940NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CEACAM31084PubTator's text mininghttps://conductscience.org/library/genes/1084NCBI Gene
CSF21437PubTator's text mininghttps://conductscience.org/library/genes/1437NCBI Gene
F52153PubTator's text mininghttps://conductscience.org/library/genes/2153NCBI Gene
ICOS29851PubTator's text mininghttps://conductscience.org/library/genes/29851NCBI Gene
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
IL2RA3559PubTator's text mininghttps://conductscience.org/library/genes/3559NCBI Gene
MLC123209PubTator's text mininghttps://conductscience.org/library/genes/23209NCBI Gene
NEWENTRY192343PubTator's text mininghttps://conductscience.org/library/genes/192343NCBI Gene
NR1I39970PubTator's text mininghttps://conductscience.org/library/genes/9970NCBI Gene
SCFV652070PubTator's text mininghttps://conductscience.org/library/genes/652070NCBI Gene
SELL6402PubTator's text mininghttps://conductscience.org/library/genes/6402NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene
TNFRSF93604PubTator's text mininghttps://conductscience.org/library/genes/3604NCBI Gene
TRBV20OR9-26962PubTator's text mininghttps://conductscience.org/library/genes/6962NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28344808

GET https://conductscience.org/api/papers/v1/28344808/references?page=2